Vedan­ta lays off CMC staffers; Kin­cell buys Imu­gene fa­cil­i­ty for $6M

Wel­come to End­points News’ man­u­fac­tur­ing briefs, where we bring you es­sen­tial news on new builds, col­lab­o­ra­tions, re­calls and more.

Vedan­ta Bio­sciences will lay off 12 work­ers from its CMC team, and a “sim­i­lar num­ber” of staffers in oth­er po­si­tions, as the com­pa­ny is “com­ing off a peak of man­u­fac­tur­ing cam­paigns that sup­plied sev­er­al mid and late-stage clin­i­cal stud­ies,” CEO Bernat Olle wrote Fri­day on LinkedIn.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.